DVA

DaVita Inc.StockHealthcare

$207.91−$2.67 (-1.27%)as of Jun 18, 4:00 PM ET

What would $1,000 invested in DVA be worth today? →

Key stats

Market cap: 13.9B
P/E (ttm): 12.5×
Fwd P/E: 12.1×
P/S: 1.0×
EPS (ttm): $10.71
EV/EBITDA: 7.9×
EV/Sales: 1.6×
P/FCF: 9.3×
FCF yield: 10.75%
Net margin: 8.05%
ROA: 6.36%
Current ratio: 1.42
Beta: 0.91
52W high: -2.59%
Rel volume: 1.56×
30D $ vol: 176.7M

Performance

-1.27%

+2.00%

+6.83%

+38.83%

YTD

+81.56%

+52.30%

+70.04%

Financial statements

Open full DVA financials →

Related Healthcare

Ticker	Theme	Price	1M	30D $Vol
LLY Eli Lilly and Company	Pharmaceuticals	$1,099	+7.55%	3.4B
JNJ Johnson & Johnson	Pharmaceuticals	$228	-0.70%	1.9B
ABBV AbbVie Inc.	Biopharma	$216	+1.28%	1.2B
UNH UnitedHealth Group Incorporated Common Stock (DE)		$401	+3.01%	2.8B
MRK Merck & Co. Inc.	Pharmaceuticals	$114	-0.32%	1.3B
AMGN Amgen Inc.	Biotech	$338	+2.07%	997.1M
TMO Thermo Fisher Scientific Inc.	Life Sciences	$465	+3.75%	1.2B
ABT Abbott Laboratories	Medical Devices	$88.41	-0.46%	1.2B

DaVita Inc. (DVA) trades at $207.91 with a live price and an interactive chart covering 23+ years of daily price history, plus key valuation metrics. ChartRow also publishes DVA's financial statements free — annual and quarterly income statement, balance sheet, and cash flow straight from SEC filings, with P/E and valuation history and dividend data. See full DVA financial statements →